Cancer Research Technology
Log in Register
Menu

Anti-Cytokeratin [PK63]

Invented by Karen Pulford from University of Oxford
Invented at University of Oxford

Info

Catalogue Number 151392
Applications IHC IF IP WB
Antigen/Gene or Protein Targets Cytokeratins of 48, 50, 56, 62 and 65-67 kDa
Reactivity Human
Relevance Keratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I keratin (keratins 9 to 23) and one type II keratin (keratins 1 to 8). Keratins demonstrate tissue and differentiation specific expression profiles.
Host Mouse
Immunogen Epidermal keratin
Subclass IgG1 kappa
Molecular Weight (kDa) 48-67
Myeloma Used P3/NS1/1-Ag4.1
Recommended Growing Conditions RPMI 1640 + 10% FCS + penicillin (100U/ml) + streptomycin (100mg/l) + glutamine (2mM) + HAT
Notes Ultroser G can be used at 1% if the cells are not growing well.
Research Area Cancer, Cell Type or Organelle Marker, Cell Signaling & Signal Transduction

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Gatter et al. 1985. J Clin Pathol. 38(12):1353-7. PMID: 3908491.

An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.

Europe PMC ID: 3908491


Add a reference

References: 2 entries

Gatter et al. 1985. J Clin Pathol. 38(12):1353-7. PMID: 3908491.

An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.


Add a reference